COVID-19 Products Had Strong 2021, But Omicron Casts Shadow Over 2022

Windfall From Drugs, Vaccines Sparks Talk Of Merger Mania

COVID globe
How the drug and vaccine market developed in 2021, and how Omicron hangs over 2022 • Source: Shutterstock
Scrip Podcast

Have you checked out Scrip podcast?

New episodes every Thursday.

More from COVID-19

More from Scrip